Federal Register / Vol. 89, No. 41 / Thursday, February 29, 2024 / Notices 14845 

Workforce Workgroup, and (9) an 

update from the Presidential Advisory 

Council on HIV/AIDS. Agenda items are 

subject to change as priorities dictate. 

Public Participation 

Written Public Comment: Members of 

the public are welcome to submit 

written comments in advance of the 

meeting. Written comments must be 

submitted by emailing nchhstppolicy@

cdc.gov with subject line ‘‘Spring CHAC 

Public Comment Registration’’ by April 

19, 2024. 

Oral Public Comment: Individuals 

who would like to make an oral 

comment during the public comment 

period must register by emailing 

nchhstppolicy@cdc.gov with subject 

line ‘‘Spring CHAC Public Comment 

Registration’’ by March 26, 2024. The 

public comment period is on April 9, 

2024, at 3:45 p.m., EDT. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2024–04197 Filed 2–28–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Meeting of the Advisory Board on 

Radiation and Worker Health, 

Subcommittee for Procedure Reviews, 

National Institute for Occupational 

Safety and Health 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

Centers for Disease Control and 

Prevention (CDC) announces the 

following meeting for the Subcommittee 

on Procedures Reviews (SPR) of the 

Advisory Board on Radiation and 

Worker Health (ABRWH or the Advisory 

Board). This meeting is open to the 

public, but without a public comment 

period. The public is also welcomed to 

listen to the meeting by joining the 

audio conference (information below). 

The audio conference line has 150 ports 

for callers. 

DATES: The meeting will be held on 

March 14, 2024, from 11 a.m. to 4:30 

p.m., EDT. 

Written comments must be received 

on or before March 7, 2024. 

ADDRESSES: You may submit comments 

by mail to: Rashaun Roberts, National 

Institute for Occupational Safety and 

Health, Centers for Disease Control and 

Prevention, 1090 Tusculum Avenue, MS 

C–24, Cincinnati, Ohio 45226. 

Meeting Information: Audio 

Conference Call via FTS Conferencing. 

The USA toll-free dial-in number is 1– 

866–659–0537; the pass code is 

9933701. 

FOR FURTHER INFORMATION CONTACT: 

Rashaun Roberts, Ph.D., Designated 

Federal Officer, National Center for 

Occupational Safety and Health, Centers 

for Disease and Prevention, 1090 

Tusculum Avenue, Mailstop C–24, 

Cincinnati, Ohio 45226, Telephone: 

(513) 533–6800; Email: ocas@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Background: The Advisory Board on 

Radiation and Worker Health (ABRWH 

or the Advisory Board) was established 

under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000 to advise the 

President on a variety of policy and 

technical functions required to 

implement and effectively manage the 

new compensation program. Key 

functions of the Advisory Board include 

providing advice on the development of 

probability of causation guidelines that 

have been promulgated by the 

Department of Health and Human 

Services (HHS) as a final rule; advice on 

methods of dose reconstruction, which 

have also been promulgated by HHS as 

a final rule; advice on the scientific 

validity and quality of dose estimation 

and reconstruction efforts being 

performed for purposes of the 

compensation program; and advice on 

petitions to add classes of workers to the 

Special Exposure Cohort. In December 

2000, the President delegated 

responsibility for funding, staffing, and 

operating the Advisory Board to HHS, 

which subsequently delegated this 

authority to CDC. NIOSH implements 

this responsibility for CDC. 

The charter was issued on August 3, 

2001, renewed at appropriate intervals, 

and rechartered under Executive Order 

14109 on March 22, 2022, and will 

terminate on March 22, 2024. 

Purpose: The Advisory Board is 

charged with (a) providing advice to the 

Secretary, HHS, on the development of 

guidelines under Executive Order 

13179; (b) providing advice to the 

Secretary, HHS, on the scientific 

validity and quality of dose 

reconstruction efforts performed for this 

program; and (c) upon request by the 

Secretary, HHS, advise the Secretary on 

whether there is a class of employees at 

any Department of Energy facility who 

were exposed to radiation but for whom 

it is not feasible to estimate their 

radiation dose, and on whether there is 

reasonable likelihood that such 

radiation doses may have endangered 

the health of members of this class. The 

ABWRH Subcommittee on Procedure 

Reviews (SPR) is responsible for 

overseeing, tracking, and participating 

in the reviews of all procedures used in 

the dose reconstruction process by the 

NIOSH Division of Compensation 

Analysis and Support (DCAS) and its 

dose reconstruction contractor (Oak 

Ridge Associated Universities—ORAU). 

Matters to be Considered: The agenda 

will include discussions on the 

following: 1. Carry-over items from 

November 16, 2023, SPR Meeting, 

including a. DCAS–PER–040 

‘‘Mallinckrodt TBD Revisions,’’ b. Peeks 

Street review—NIOSH, and c. ANL–W 

TBD revision—review application of 

ORAUT–RPRT–0097. 2. Newly-issued 

SC&A reviews, including a. ORAUT– 

RPRT–0071 ‘‘External Dose Coworker 

Methodology,’’ b. ORAUT–RPRT–0084 

‘‘Two-Count Filter Method for 

Measurement of Thoron Progeny in 

Air,’’ c. DCAS–PER–047 ST4 ‘‘GJOO,’’ d. 

‘‘Amchitka Island template,’’ e. 

‘‘Albuquerque Operations Office 

template,’’ f. DCAS–PER–068 ‘‘Electro 

Metallurgical Co,’’ g. DCAS–PER–070 

‘‘Nuclear Metals Inc.,’’ h. DCAS–PER– 

072 ‘‘Seymour Specialty Wiring Co,’’ i. 

ORAUT–RPRT–0060 ‘‘Neutron Dose 

from Highly Enriched Uranium.’’; 3. 

PERs previously identified as not 

needing a review; 4. Preparation for 

April 2024 Full ABRWH Meeting: 

Review of technical guidance 

documents ready for full Board 

approval; 5. Newly-Issued Guidance and 

Supplemental Topics. Agenda items are 

subject to change as priorities dictate. 

For additional information, please 

contact Toll Free 1 (800) 232–4636. 

Meeting Information: Audio 

Conference Call via FTS Conferencing. 

The USA toll-free dial-in number is 1– 

866–659–0537; the pass code is 

9933701. 

Public Participation 

Written Public Comment: The public 

is welcome to submit written comments 


khammond on DSKJM1Z7X2PROD with NOTICES
14846 Federal Register / Vol. 89, No. 41 / Thursday, February 29, 2024 / Notices 

in advance of the meeting, to Rashaun 

Roberts, Ph.D., Designated Federal 

Officer, National Center for 

Occupational Safety and Health, Centers 

for Disease and Prevention, 1090 

Tusculum Avenue, Mailstop C–24, 

Cincinnati, Ohio 45226, Telephone: 

(513) 533–6800; Email: ocas@cdc.gov. 

Written comments received in advance 

of the meeting will be included in the 

official record of the meeting. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2024–04210 Filed 2–28–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP)—RFA–IP–24– 

046, Nationwide Cohort To Estimate 

Burden of Respiratory Viruses and 

Immunologic Response (Blood Donor 

Cohort); Amended Notice of Closed 

Meeting 

Notice is hereby given of a change in 

the closed meeting of the Disease, 

Disability, and Injury Prevention and 

Control Special Emphasis Panel (SEP)— 

RFA–IP–24–046, Nationwide Cohort to 

Estimate Burden of Respiratory Viruses 

and Immunologic Response (Blood 

Donor Cohort); April 11–12, 2024, 10 

a.m.–5 p.m., EDT, videoconference, in 

the original Federal Register notice. The 

meeting notice was published in the 

Federal Register on January 16, 2024, 

Volume 89, Number 10, pages 2618– 

2619. 

The notice is being amended to 

change the meeting dates to a one-day 

meeting and should read as follows: 

Name of Committee: Disease, 

Disability, and Injury Prevention and 

Control Special Emphasis Panel (SEP)— 

RFA–IP–24–046, Nationwide Cohort to 

Estimate Burden of Respiratory Viruses 

and Immunologic Response (Blood 

Donor Cohort). 

Date: April 11, 2024. 

Time: 10 a.m.–5 p.m., EDT. 

The meeting is closed to the public. 

For Further Information Contact: 

Gregory Anderson, M.S., M.P.H., 

Scientific Review Officer, National 

Center for HIV, Viral Hepatitis, STD, 

and TB Prevention, Centers for Disease 

Control and Prevention, 1600 Clifton 

Road NE, Mailstop H24–6, Atlanta, 

Georgia 30329–4027. Telephone: (404) 

718–8833; Email: GAnderson@cdc.gov. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2024–04199 Filed 2–28–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifiers: CMS–10706 and 

CMS–10526] 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 

(PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information (including each proposed 

extension or reinstatement of an existing 

collection of information) and to allow 

60 days for public comment on the 

proposed action. Interested persons are 

invited to send comments regarding our 

burden estimates or any other aspect of 

this collection of information, including 

the necessity and utility of the proposed 

information collection for the proper 

performance of the agency’s functions, 

the accuracy of the estimated burden, 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected, and the use of automated 

collection techniques or other forms of 

information technology to minimize the 

information collection burden. 

DATES: Comments must be received by 

April 29, 2024. 

ADDRESSES: When commenting, please 

reference the document identifier or 

OMB control number. To be assured 

consideration, comments and 

recommendations must be submitted in 

any one of the following ways: 

1. Electronically. You may send your 

comments electronically to http://

www.regulations.gov. Follow the 

instructions for ‘‘Comment or 

Submission’’ or ‘‘More Search Options’’ 

to find the information collection 

document(s) that are accepting 

comments. 

2. By regular mail. You may mail 

written comments to the following 

address: CMS, Office of Strategic 

Operations and Regulatory Affairs, 

Division of Regulations Development, 

Attention: Document Identifier/OMB 

Control Number: ll, Room C4–26–05, 

7500 Security Boulevard, Baltimore, 

Maryland 21244–1850. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, please access the CMS PRA 

website by copying and pasting the 

following web address into your web 

browser: https://www.cms.gov/ 

Regulations-and-Guidance/Legislation/

PaperworkReductionActof1995/PRAListing. 

FOR FURTHER INFORMATION CONTACT: 

William N. Parham at (410) 786–4669. 

SUPPLEMENTARY INFORMATION: 

Contents 

This notice sets out a summary of the 

use and burden associated with the 

following information collections. More 

detailed information can be found in 

each collection’s supporting statement 

and associated materials (see 

ADDRESSES). 

CMS–10706 Generic Clearance for the 

Center for Clinical Standards and 

Quality IT Product and Support 

Teams 

CMS–10526 Cost-sharing Reduction 

Reconciliation 

Under the PRA (44 U.S.C. 3501– 

3520), federal agencies must obtain 

approval from the Office of Management 

and Budget (OMB) for each collection of 


khammond on DSKJM1Z7X2PROD with NOTICES